Annual report pursuant to Section 13 and 15(d)

Stock-based compensation - Stock option activity (Details)

v3.22.1
Stock-based compensation - Stock option activity (Details) - Stock Options
$ / shares in Units, $ in Millions
8 Months Ended 12 Months Ended
Jan. 31, 2022
USD ($)
$ / shares
shares
Jan. 31, 2022
USD ($)
$ / shares
shares
Shares    
Granted (in shares) | shares 2,825,752  
Outstanding at end period (in shares) | shares 2,825,752 2,825,752
Vested and exercisable (in shares) | shares 125,000 125,000
Weighted Average Exercise Price    
Weighted Average Exercise Price Granted (in dollars per share) | $ / shares $ 10.76  
Weighted Average Exercise Price Outstanding at end period (in dollars per share) | $ / shares 10.76 $ 10.76
Weighted Average Exercise Price Vested and Exercisable (in dollars per share) | $ / shares $ 10.75 $ 10.75
Weighted Average Remaining Contractual Term (Years)    
Weighted Average Remaining Contractual Term Outstanding (in Years) 9 years 4 months 24 days  
Unrecognized equity-based compensation costs | $ $ 8.1 $ 8.1
Cost expected to be recognized over a weighted-average period   3 years 4 months 24 days